Show simple item record

dc.contributor.authorHobson, RJ
dc.contributor.authorSewell, GJ
dc.date.accessioned2015-10-27T16:30:35Z
dc.date.available2015-10-27T16:30:35Z
dc.date.issued2006-10-03
dc.identifier.issn0928-1231
dc.identifier.issn1573-739X
dc.identifier.urihttp://hdl.handle.net/10026.1/3720
dc.description.abstract

UNLABELLED: OBJECTIVE (OF THE STUDY): To provide data on the views of chief pharmacists (CPs) and primary care trust pharmacists (PCTPs) on the risks and concerns surrounding supplementary prescribing. SETTING: Secondary and primary care within England. METHOD: Postal questionnaire surveys of chief pharmacists and primary care trust pharmacists. MAIN OUTCOME MEASURE: Significance of the association between the extracted factors. RESULTS: The response rate was 68% for both the primary care (183/271) and secondary care surveys (97/143). The survey tool was subjected to factor analysis and reliability testing. For both sectors, the three factors that were extracted described concerns over the training model for supplementary prescribing, concerns about the professional competency/responsibility of the supplementary prescribers once trained, and positivity about the implementation of supplementary prescribing. For both sectors, as trusts have more experience of supplementary prescribing by nurses, the respondents had less concerns about the supplementary prescribing training model. For secondary care, as the total number of pharmacists employed within the trust increases, the respondents had less concerns over the limitations of the supplementary prescribing training model. CONCLUSION: Although both sectors have concerns over the training model for supplementary prescribing and also professional competence and responsibility once trainees qualify, there is overall a positive attitude towards supplementary prescribing and there is a belief that pharmacists wish to take this role on.

dc.format.extent76-90
dc.format.mediumPrint-Electronic
dc.languageen
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.subjectsupplementary prescribing
dc.subjectpharmacist
dc.subjectfactor analysis
dc.subjectquestionnaire
dc.subjectnursing
dc.subjectrisk
dc.subjectUnited Kingdom
dc.subjectopinions
dc.titleRisks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists
dc.typejournal-article
dc.typeJournal Article
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241011000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue2
plymouth.volume28
plymouth.publication-statusPublished
plymouth.journalPharmacy World & Science
dc.identifier.doi10.1007/s11096-006-9004-z
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy MANUAL
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Health and Community
plymouth.organisational-group/Plymouth/Users by role
dc.publisher.placeGermany
dcterms.dateAccepted2006-01-28
dc.identifier.eissn1573-739X
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1007/s11096-006-9004-z
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2006-04
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV